Catherine Petit

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Treatment of Ventilator‐Associated Pneumonia with Piperacillin‐Tazobactam/Amikacin Versus Ceftazidime/Amikacin: A Multicenter, Randomized Controlled Trial

C. Brun‐Buisson, J.-P. Sollet, H. Schweich et al. · Clinical Infectious Diseases · 1998 · 111 citations · Full text

Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: Results from the randomized Optima study

Bruno Guerci, Louis Monnier, Pierre Sérusclat et al. · Diabetes & Metabolism · 2012 · 80 citations

Metabolic Syndrome, Diabetes Management, Biochemistry +13

Clinical and Metabolic Features of Adult-Onset Diabetes Caused by <i>ABCC8</i> Mutations

Jean‐Pierre Riveline, Elise Rousseau, Yves Reznik et al. · Diabetes Care · 2011 · 50 citations · Full text